<DOC>
	<DOCNO>NCT01948336</DOCNO>
	<brief_summary>The aim study evaluate effect dexmedetomidine infusion early stage renal function .</brief_summary>
	<brief_title>The Effects Dexmedetomidine Early Stage Renal Functions Pediatric Patients</brief_title>
	<detailed_description>Background : Contrast-induced nephropathy third common cause acute renal failure hospitalize patient age group . In study aim investigate effect dexmedetomidine early stage renal function pediatric patient undergoing cardiac angiography . Methods : 60 pediatric patient 6 72 month age undergoing cardiac angiography include study . Patients divide two group . The patient group administer 1mgkg-1 ketamine , 1mgkg-1 propofol bolus follow 1 mgkg-1hour-1 ketamine 50 µgkg-1min-1 propofol infusion . Additionally , load dose 1 µgkg-1 dexmedetomidine give 10 minute follow 0.5 µgkg-1hour-1 dexmedetomidine infusion patient group D. The patient evaluate NGAL , creatinine , renin , endothelin-1 , TAS TOS blood level procedure 6th 24th hour procedure . pRIFLE criterion use define CIN incidence study .</detailed_description>
	<mesh_term>Renal Insufficiency</mesh_term>
	<mesh_term>Propofol</mesh_term>
	<mesh_term>Dexmedetomidine</mesh_term>
	<mesh_term>Ketamine</mesh_term>
	<criteria>6 72 month child schedule cardiac angiography patient renal failure diabetes mellitus , patient nephrotoxic vasoactive drug simultaneously , patient decompensated congestive heart failure patient administer contrast medium last two week</criteria>
	<gender>All</gender>
	<minimum_age>6 Months</minimum_age>
	<maximum_age>72 Months</maximum_age>
	<verification_date>September 2013</verification_date>
	<keyword>Contrast-induced nephropathy , Dexmedetomidine , Endothelin-1</keyword>
</DOC>